Company: CDT
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022373
Chunk: 55

Company: CDT Equity Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 55
---
 However, we may be unable to raise additional funds or enter into such other arrangements, when
needed, on favorable terms or at all. To the extent that we raise additional capital through the sale of equity or convertible debt
securities, the ownership interest of our stockholders will be, or could be, diluted, and the terms of these securities may include
liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing,
if available, may involve agreements that include covenants, limiting or restricting our ability to take specific actions, such as
incurring additional debt, making capital expenditures or declaring dividends. We have also considered exploring strategic
alternative paths to fund raising through a shift in our fundamental operations as a pharmaceutical development company to a digital
asset treasury management company. If we are unable to raise additional funds through equity or debt financing when needed, we may
be required to delay, limit, or substantially reduce research and development efforts all of which could have a material adverse
effect on the Company and its financial results.

While
the Company believes in the viability of its ability to raise additional funds, there can be no assurances to that effect. We have based
our estimates on assumptions of operating costs that may prove to be wrong. As a result, we could deplete our capital resources sooner
than we currently expect. If, for any reason, our expenses differ materially from our assumptions or we utilize our cash more quickly
than anticipated, or if we are unable to obtain funding on a timely basis we may be required to revise our business plan and strategy,
which may result in significantly curtailing, delaying or discontinuing one or more of our research or development programs or the commercialization
of any product candidates or may result in our being unable to expand our operations or otherwise capitalize on our business opportunities.
As a result, our business, financial condition, and results of operations could be materially affected.

Management
has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of at least 12 months
from the date of the filing of this Quarterly Report. This is based on our analysis under applicable accounting principles. These financial
statements have been prepared assuming the Company will continue as a going concern and do not include adjustments to reflect the possible
effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the
outcome of this uncertainty.

Cash
Requirements

Our
material cash requirements include the following contractual and other obligations